Effects of ACE Inhibitors or ↓-Blockers in Patients Treated with the Fixed-Dose Combination of Isosorbide Dinitrate/Hydralazine in the African-American Heart Failure Trial

被引：0

作者：

Jalal K. Ghali

S. William Tam

Keith C. Ferdinand

JoAnn Lindenfeld

Michael L. Sabolinski

Anne L. Taylor

Manuel Worcel

Charles L. Curry

Jay N. Cohn

机构：

[1] University Health Center,Cardiovascular Division, Department of Medicine

[2] 2E,undefined

[3] Wayne State University,undefined

[4] NitroMed,undefined

[5] Inc.,undefined

[6] Black Cardiologist Association,undefined

[7] University Hospital,undefined

[8] University of Colorado,undefined

[9] University of Minnesota,undefined

[10] Howard University,undefined

[11] College of Medicine,undefined

来源：

American Journal of Cardiovascular Drugs | 2007年 / 7卷

关键词：

Heart Failure; Nitric Oxide; Enalapril; Systolic Heart Failure; Heart Failure Hospitalization;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：373 / 380

页数：7

共 50 条

[11] Effect of angiotensin converting enzyme inhibitor or beta-blocker use on the benefit of fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American heart failure trial
Ghali, Jalal K.
Taylor, Anne L.
Tam, S. W.
Sabolinski, Michael L.
Worcel, Manuel
Cohn, Jay N.
CIRCULATION, 2006, 114 (18) : 572 - 572
[12] Impact of fixed-dose combination of isosorbide dinitrate and hydralazine on heart failure progression in an African American population: Focus on mode of death and hospitalization
Carson, Peter
Anand, Inder
Ghali, Jalal K.
Lindenfeld, JoAnn
Miller, Alan B.
Tristani, Felix
Braman, Virginia M.
Worcel, Manuel
Sabolinski, Michael L.
CIRCULATION, 2006, 114 (18) : 572 - 572
[13] Cost-effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine therapy for black patients with heart failure
Tam, SW
Linde-Zwirble, WT
Worcel, M
Sabolinski, ML
Ghali, JK
Villagra, VG
Winkelmayer, WC
Angus, DC
CIRCULATION, 2005, 112 (17) : U705 - U705
[14] A review of isosorbide dinitrate and hydralazine in the management of heart failure in black patients, with a focus on a new fixed-dose combination
Cheng, Judy W. M.
CLINICAL THERAPEUTICS, 2006, 28 (05) : 666 - 678
[15] Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine - Consistency across subgroups in the African-American Heart Failure Trial
Taylor, Anne L.
Ziesche, Susan
Yancy, Clyde W.
Carson, Peter
Ferdinand, Keith
Taylor, Malcolm
Adams, Kirkwood
Olukotun, Adeoye Y.
Ofili, Elizabeth
Tam, S. William
Sabolinski, Michael L.
Worcel, Manuel
Cohn, Jay N.
CIRCULATION, 2007, 115 (13) : 1747 - 1753
[16] In-trial economic evaluation of a fixed-dose combination of isosorbide dinitirate and hydralazine in blacks with heart failure: Results from the African-American Heart Failure Trial (A-HeFT)
Linde-Zwirble, WT
Tam, SW
Worcel, M
Sabolinski, ML
Ghali, J
Angus, DC
JOURNAL OF CARDIAC FAILURE, 2005, 11 (06) : S151 - S151
[17] Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate in African-American Patients With Heart Failure
Ziaeian, Boback
Fonarow, Gregg C.
Heidenreich, Paul A.
JACC-HEART FAILURE, 2017, 5 (09) : 632 - 639
[18] Cost-effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine therapy for blacks with heart failure
Angus, DC
Linde-Zwirble, WT
Tam, SW
Ghali, JK
Sabolinski, ML
Villagra, VG
Winkelmayer, WC
Worcel, M
CIRCULATION, 2005, 112 (24) : 3745 - 3753
[19] Effect of angiotensin converting enzyme inhibitor or beta-blocker use on the benefit of fixed-dose combined isosorbide dinitrate/hydralazine in the African-American heart failure trial
Ghali, Jalal K.
Taylor, Anne L.
Tam, S. William
Sabolinski, Michael L.
Worcel, Manuel
Cohn, Jay N.
JOURNAL OF CARDIAC FAILURE, 2006, 12 (06) : S80 - S80
[20] Fixed-dose combination of isosorbide dinitrate and hydralazine improves quality of life in African Americans with heart failure: Results from A-HeFT
Carson, P
Ghali, J
Tam, SW
Worcel, M
JOURNAL OF CARDIAC FAILURE, 2005, 11 (06) : S150 - S150

← 1 2 3 4 5 →